Carotid intima-media thickness is increased in patients with mucopolysaccharidoses

Molecular Genetics and Metabolism

Volumn 104, Issue 4, 2011, Pages 592-596

  Wang, Raymond Y ^a,b   Covault, Kelly K ^a   Halcrow, Eileen M ^c   Gardner, Audrey J ^a   Cao, Xiaoling ^a   Newcomb, Robert L ^d   Dauben, Richard D ^c   Chang, Anthony C ^a  

^a CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ST JOSEPH HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiac vascular outcome; Intima Media thickness; Lysosomal storage; Marker; Mucopolysaccharidosis; Treatment

Indexed keywords

BIOLOGICAL MARKER; GLYCOSAMINOGLYCAN;

AORTA VALVE REGURGITATION; ARTERIAL WALL THICKNESS; ARTICLE; BIOACCUMULATION; BODY HEIGHT; BODY WEIGHT; CAROTID ARTERY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORRELATION ANALYSIS; DISEASE MARKER; ECHOCARDIOGRAPHY; ECHOGRAPHY; ENZYME REPLACEMENT; ETHNICITY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MITRAL VALVE REGURGITATION; MUCOPOLYSACCHARIDOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION;

ADOLESCENT; BIOLOGICAL MARKERS; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CORONARY VESSELS; FEMALE; HEART VALVE DISEASES; HUMANS; MALE; MUCOPOLYSACCHARIDOSES; YOUNG ADULT;

EID: 82255175877     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.09.004     Document Type: Article

References (28)

1. E.F. Neufeld, J. Muenzer, The Mucopolysaccharidoses, in: C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.), The online metabolic and molecular bases of inherited disease - OMMBID. , New York: McGraw-Hill; (2001) Chap. 136. Accessed 3/1/2011. doi:. http://doi:10.1036/ommbid.165.
2. Peters C., Shapiro E.G., Anderson J., Henslee-Downey P.J., Klemperer M.R., Cowan M.J., Saunders E.F., deAlarcon P.A., Twist C., Nachman J.B., Hale G.A., Harris R.E., Rozans M.K., Kurtzberg J., Grayson G.H., Williams T.E., Lenarsky C., Wagner J.E., Krivit W. Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. Blood 1998, 91:2601-2608.
3. Wraith J.E., Clarke L.A., Beck M., Kolodny E.H., Pastores G.M., Muenzer J., Rapoport D.M., Berger K.I., Sidman M., Kakkis E.D., Cox G.F. Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase). J. Pediatr. 2004, 144:581-588.
4. Harmatz P., Giugliani R., Schwartz I.V., Guffon N., Teles E.L., Miranda M.C., Wraith J.E., Beck M., Arash L., Scarpa M., Ketteridge D., Hopwood J.J., Plecko B., Steiner R., Whitley C.B., Kaplan P., Swiedler S.J., Hardy K., Berger K.I., Decker C. Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase. Mol. Genet. Metab. 2008, 94:469-475.
5. Souillet G., Guffon N., Maire I., Pujol M., Taylor P., Sevin F., Bleyzac N., Mulier C., Durin A., Kebaili K., Galambrun C., Bertrand Y., Froissart R., Dorche C., Gebuhrer L., Garin C., Berard J., Guibaud P. Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources. Bone Marrow Transplant. 2003, 31:1105-1117.
6. Wraith J.E. Limitations of enzyme replacement therapy: current and future. J. Inherit. Metab. Dis. 2006, 29:442-447.
7. Braunlin E.A., Berry J.M., Whitley C.B. Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I. Am. J. Cardiol. 2006, 98:416-418.
8. Fesslová V., Corti P., Sersale G., Rovelli A., Russo P., Mannarino S., Butera G., Parini R. The natural course and the impact of therapies of cardiac involvement in the mucopolysaccharidoses. Cardiol. Young 2009, 19:170-178.
9. Yano S., Moseley K., Pavlova Z. Postmortem studies on a patient with mucopolysaccharidosis type I: histopathological findings after one year of enzyme replacement therapy. J. Inherit. Metab. Dis. 2009, 10.1007/s10545-009-1057-4.
10. Leal G.N., de Paula A.C., Leone C., Kim C.A. Echocardiographic study of paediatric patients with mucopolysaccharidosis. Cardiol. Young 2010, 20:254-261.
11. van den Broek L., Backx A.P., Coolen H., Wijburg F.A., Wevers R., Morava E., Neeleman C. Fatal coronary artery disease in an infant with severe mucopolysaccharidosis type I. Pediatrics 2011, 127:e1343-e1346.
12. Jones S.A., Almássy Z., Beck M., Burt K., Clarke J.T., Giugliani R., Hendriksz C., Kroepfl T., Lavery L., Lin S.P., Malm G., Ramaswami U., Tincheva R., Wraith J.E. HOS Investigators, Mortality and cause of death in mucopolysaccharidosis type II-a: historical review based on data from the Hunter Outcome Survey (HOS). J. Inherit. Metab. Dis. 2009, 32:534-543.
13. Braunlin E.A., Harmatz P.R., Scarpa M., Furlanetto B., Kampmann C., Loehr J.P., Ponder K.P., Roberts W.C., Rosenfeld H.M., Giugliani R. Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management. J. Inherit. Metab. Dis. 2011, 10.1007/s10545-011-9359-8.
14. Golda A., Jurecka A., Tylki-Szymanska A. Cardiovascular manifestations of mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome). Int. J. Cardiol. 2011, 10.1016/j.ijcard.2011.06.097.
15. Lorenz M.W., Markus H.S., Bots M.L., Rosvall M., Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007, 115:459-467.
16. Sass C., Herbeth B., Chapet O., Siest G., Visvikis S., Zannad F. Intima-media thickness and diameter of carotid and femoral arteries in children, adolescents and adults from the Stanislas cohort: effect of age, sex, anthropometry and blood pressure. J. Hypertens. 1998, 16:1593-1602.
17. Jourdan C., Wühl E., Litwin M., Fahr K., Trelewicz J., Jobs K., Schenk J.P., Grenda R., Mehls O., Tröger J., Schaefer F. Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. J. Hypertens. 2005, 23:1707-1715.
18. Davis P.H., Dawson J.D., Riley W.A., Lauer R.M. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine study. Circulation 2001, 104:2815-2819.
19. Sabri M.R., Kelishadi R. The thickness of the intimal and medial layers of the carotid arteries, and the index of left ventricular mass, in children of patients with premature coronary arterial disease. Cardiol. Young 2007, 17:609-616.
20. Barra S., Gaeta G., Cuomo S., Guarini P., Foglia M.C., Capozzi G., Materazzi C., Trevisan M. Early increase of carotid intima-media thickness in children with parental history of premature myocardial infarction. Heart 2009, 95:642-645.
21. Kockx M., Jessup W., Kritharides L. Cyclosporin A and atherosclerosis-cellular pathways in atherogenesis. Pharmacol. Ther. 2010, 128:106-118.
22. Braunlin E.A., Rose A.G., Hopwood J.J., Candel R.D., Krivit W. Coronary artery patency following long-term successful engraftment 14years after bone marrow transplantation in the Hurler syndrome. Am. J. Cardiol. 2001, 88:1075-1077.
23. Lin H.Y., Lin S.P., Chuang C.K., Chen M.R., Chen B.F., Wraith J.E. Mucopolysaccharidosis I under enzyme replacement therapy with laronidase-a mortality case with autopsy report. J. Inherit. Metab. Dis. 2005, 28:1146-1148.
24. Palpant N.J., Bedada F.B., Peacock B., Blazar B.R., Metzger J.M., Tolar J. Cardiac disease in mucopolysaccharidosis type I attributed to catecholaminergic and hemodynamic deficiencies. Am. J. Physiol. Heart Circ. Physiol. 2011, 300:H356-H365.
25. Su T.C., Chien K.L., Jeng J.S., Chang C.J., Hsu H.C., Chen M.F., Sung F.C., Lee Y.T. Pulse pressure, aortic regurgitation and carotid atherosclerosis: a comparison between hypertensives and normotensives. Int. J. Clin. Pract. 2006, 60:134-140.
26. Sleeper M.M., Fornasari B., Ellinwood N.M., Weil M.A., Melniczek J., O'Malley T.M., Sammarco C.D., Xu L., Ponder K.P., Haskins M.E. Gene therapy ameliorates cardiovascular disease in dogs with mucopolysaccharidosis VII. Circulation 2004, 110:815-820.
27. Liu Y., Xu L., Hennig A.K., Kovacs A., Fu A., Chung S., Lee D., Wang B., Herati R.S., Ogilvie J.M., Cai S.R., Ponder K.P. Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice. Mol. Ther. 2005, 11:35-47.
28. Traas A.M., Wang P., Ma X., Tittiger M., Schaller L., O'donnell P., Sleeper M.M., Vite C., Herati R., Aguirre G.D., Haskins M., Ponder K.P. Correction of clinical manifestations of canine mucopolysaccharidosis I with neonatal retroviral vector gene therapy. Mol. Ther. 2007, 15:1423-1431.